A detailed history of Personal Cfo Solutions, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Personal Cfo Solutions, LLC holds 75,000 shares of ARDX stock, worth $411,750. This represents 0.07% of its overall portfolio holdings.

Number of Shares
75,000
Previous 70,000 7.14%
Holding current value
$411,750
Previous $518,000 0.39%
% of portfolio
0.07%
Previous 0.08%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.28 - $7.57 $26,400 - $37,850
5,000 Added 7.14%
75,000 $516,000
Q4 2023

Feb 13, 2024

BUY
$3.29 - $6.64 $48,576 - $98,039
14,765 Added 26.73%
70,000 $434,000
Q2 2023

Aug 10, 2023

BUY
$3.23 - $4.95 $48,450 - $74,250
15,000 Added 37.28%
55,235 $187,000
Q2 2022

Aug 05, 2022

BUY
$0.51 - $1.17 $10,319 - $23,674
20,235 Added 101.18%
40,235 $24,000
Q3 2021

Nov 18, 2021

SELL
$1.27 - $8.17 $50,800 - $326,800
-40,000 Reduced 66.67%
20,000 $26,000
Q4 2019

Feb 13, 2020

BUY
$4.23 - $8.29 $253,800 - $497,399
60,000 New
60,000 $450,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $849M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Personal Cfo Solutions, LLC Portfolio

Follow Personal Cfo Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.